The use of simulated annealing for finding optimal population designs

被引:44
作者
Duffull, SB [1 ]
Retout, S
Mentré, F
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
[2] CHU Pitie Salpetriere, INSERM U436, F-75013 Paris, France
关键词
fisher information matrix; optimal designs; D-optimality; simulated annealing; simplex; population pharmacokinetics;
D O I
10.1016/S0169-2607(01)00178-X
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
The development of functions for MATLAB and S-PLUS that can be used for the evaluation of specific Population pharmacokinetic designs has been described recently. These functions are based on the evaluation of an approximation of the population Fisher information matrix. Optimisation of the design of the population experiment can be made on the basis of D-optimal design techniques, where the determinant of the population Fisher information matrix is maximised. This maximisation is complex due to the convoluted nature of the surface of the determinant. Four optimisation algorithms (simplex, non-adaptive random search, non-adaptive random search followed by simplex and simulated annealing) are compared in their ability to optimise the sampling times for various design structures for three examples of population pharmacokinetic models. In all cases, despite more computing time, simulated annealing was superior to the other methods for finding optimal designs with greater benefits being seen over the other algorithms for the more complex designs. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 16 条
[1]   EXPERIMENTAL-DESIGN AND EFFICIENT PARAMETER-ESTIMATION IN POPULATION PHARMACOKINETICS [J].
ALBANNA, MK ;
KELMAN, AW ;
WHITING, B .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1990, 18 (04) :347-360
[2]   INCORPORATING PRIOR PARAMETER UNCERTAINTY IN THE DESIGN OF SAMPLING SCHEDULES FOR PHARMACOKINETIC PARAMETER-ESTIMATION EXPERIMENTS [J].
DARGENIO, DZ .
MATHEMATICAL BIOSCIENCES, 1990, 99 (01) :105-118
[3]   Optimal design of a population pharmacodynamic experiment for ivabradine [J].
Duffull, SB ;
Mentré, F ;
Aarons, L .
PHARMACEUTICAL RESEARCH, 2001, 18 (01) :83-89
[4]  
ENDRENYI L, 1981, KINETIC DATA ANAL
[5]   GLOBAL OPTIMIZATION OF STATISTICAL FUNCTIONS WITH SIMULATED ANNEALING [J].
GOFFE, WL ;
FERRIER, GD ;
ROGERS, J .
JOURNAL OF ECONOMETRICS, 1994, 60 (1-2) :65-99
[6]   Design of cross-over trials for pharmacokinetic studies [J].
Jones, B ;
Wang, J ;
Jarvis, P ;
Byrom, W .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1999, 78 (1-2) :307-316
[8]   APPLICATION OF FAST SIMULATED ANNEALING TO OPTIMIZATION OF CONFORMAL RADIATION TREATMENTS [J].
MAGERAS, GS ;
MOHAN, R .
MEDICAL PHYSICS, 1993, 20 (03) :639-647
[9]   Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis:: An application to basiliximab in renal transplantation [J].
Mentré, F ;
Kovarik, J ;
Gerbeau, C .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (02) :213-230
[10]   Optimal design in random-effects regression models [J].
Mentre, F ;
Mallet, A ;
Baccar, D .
BIOMETRIKA, 1997, 84 (02) :429-442